146 related articles for article (PubMed ID: 15358692)
1. Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency.
Hallstrand TS; Ochs HD; Zhu Q; Liles WC
Eur Respir J; 2004 Sep; 24(3):367-70. PubMed ID: 15358692
[TBL] [Abstract][Full Text] [Related]
2. Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.
Hwang JH; Koh WJ; Kim EJ; Kang EH; Suh GY; Chung MP; Kim H; Kwon OJ
Tuberculosis (Edinb); 2006 Sep; 86(5):382-5. PubMed ID: 16682253
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.
Holland SM; Eisenstein EM; Kuhns DB; Turner ML; Fleisher TA; Strober W; Gallin JI
N Engl J Med; 1994 May; 330(19):1348-55. PubMed ID: 7908719
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of interferon-gamma and interferon-gamma receptor 1 genes and non-tuberculous mycobacterial lung diseases.
Hwang JH; Kim EJ; Koh WJ; Kim SY; Lee SH; Suh GY; Kwon OJ; Ki CS; Ji Y; Kang M; Kim DH
Tuberculosis (Edinb); 2007 Mar; 87(2):166-71. PubMed ID: 17023216
[TBL] [Abstract][Full Text] [Related]
5. Aerosolized interferon gamma for Mycobacterium avium-complex lung disease.
Chatte G; Panteix G; Perrin-Fayolle M; Pacheco Y
Am J Respir Crit Care Med; 1995 Sep; 152(3):1094-6. PubMed ID: 7663788
[TBL] [Abstract][Full Text] [Related]
6. IFN-α cannot substitute lack of IFN-γ responsiveness in cells of an IFN-γR1 deficient patient.
van de Wetering D; van Wengen A; Savage ND; van de Vosse E; van Dissel JT
Clin Immunol; 2011 Mar; 138(3):282-90. PubMed ID: 21216674
[TBL] [Abstract][Full Text] [Related]
7. Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria.
Greinert U; Schlaak M; Rüsch-Gerdes S; Flad HD; Ernst M
J Clin Immunol; 2000 Nov; 20(6):445-52. PubMed ID: 11202234
[TBL] [Abstract][Full Text] [Related]
8. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
[TBL] [Abstract][Full Text] [Related]
9. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation.
Frucht DM; Holland SM
J Immunol; 1996 Jul; 157(1):411-6. PubMed ID: 8683146
[TBL] [Abstract][Full Text] [Related]
10. Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease.
Ryu YJ; Kim EJ; Lee SH; Kim SY; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
Eur Respir J; 2007 Oct; 30(4):736-42. PubMed ID: 17567674
[TBL] [Abstract][Full Text] [Related]
11. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.
Dorman SE; Holland SM
J Clin Invest; 1998 Jun; 101(11):2364-9. PubMed ID: 9616207
[TBL] [Abstract][Full Text] [Related]
12. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency.
Allende LM; López-Goyanes A; Paz-Artal E; Corell A; García-Pérez MA; Varela P; Scarpellini A; Negreira S; Palenque E; Arnaiz-Villena A
Clin Diagn Lab Immunol; 2001 Jan; 8(1):133-7. PubMed ID: 11139207
[TBL] [Abstract][Full Text] [Related]
13. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
Davis KK; Kao PN; Jacobs SS; Ruoss SJ
BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
[TBL] [Abstract][Full Text] [Related]
14. Macrophages are a significant source of type 1 cytokines during mycobacterial infection.
Wang J; Wakeham J; Harkness R; Xing Z
J Clin Invest; 1999 Apr; 103(7):1023-9. PubMed ID: 10194475
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency.
Lim A; Allison C; Price P; Waterer G
Clin Immunol; 2010 Nov; 137(2):296-302. PubMed ID: 20797909
[TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacterial pulmonary infections in Non-HIV patients.
Parrish SC; Myers J; Lazarus A
Postgrad Med; 2008 Nov; 120(4):78-86. PubMed ID: 19020369
[TBL] [Abstract][Full Text] [Related]
17. No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection.
Lauw FN; van Der Meer JT; de Metz J; Danner SA; van Der Poll T
Clin Infect Dis; 2001 Feb; 32(4):e81-2. PubMed ID: 11181141
[TBL] [Abstract][Full Text] [Related]
18. CD4+ cells play a limited role in murine lung infection with Mycobacterium kansasii.
Wieland CW; Florquin S; Pater JM; Weijer S; van der Poll T
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):167-73. PubMed ID: 16195537
[TBL] [Abstract][Full Text] [Related]
19. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
Kim SH; Cho D; Kim TS
Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
